| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 12/02/2004 | WO2004104022A2 Compositions comprising pathogen elicited epithelial chemoattractant (eicosanoid hepoxilin a3), inhibitors thereof and methods of use thereof |
| 12/02/2004 | WO2004103408A2 Vaccine composition comprising iron phosphate as a pharmaceutical aid to said vaccine |
| 12/02/2004 | WO2004103402A1 Avian e. coli vaccine for the protection against colibacillosis |
| 12/02/2004 | WO2004103401A2 Avian combination-vaccine against e.coli and salmonella |
| 12/02/2004 | WO2004103400A2 Multivalent meningococcal derivatized polysaccharide-protein conjugates and corresponding vaccines |
| 12/02/2004 | WO2004103313A2 Methods of reducing vascular permeability in tissue by inhibition of tissue plasminogen activator (tpa) and tpa inhibitors useful therein |
| 12/02/2004 | WO2004103312A2 Peptides useful as hiv fusion inhibitors |
| 12/02/2004 | WO2004103293A2 Modulators of the p2y10 receptor useful in altering t lymphocyte function |
| 12/02/2004 | WO2004103288A2 Method of preventing recurrent miscarriages |
| 12/02/2004 | WO2004103271A2 Disease prevention and vaccination prior to thymic reactivations |
| 12/02/2004 | WO2004103269A2 Methods and compositions for vaccination comprising nucleic acid and/or polypeptide sequences of the genus borrelia |
| 12/02/2004 | WO2004092201A3 Enhanced hiv-1 vaccines and methods for their use |
| 12/02/2004 | WO2004090095A3 Generation of human regulatory t cells by bacterial toxins for the treatment of inflammatory disorders |
| 12/02/2004 | WO2004089408A3 Vaccine preparations comprising live or killed attenuated mutant neisseria bacteria |
| 12/02/2004 | WO2004084935A3 Francisella strain for live vaccine |
| 12/02/2004 | WO2004082569A3 Diagnostics and therapeutics for diseases associated with dopamine receptor d3 (drd3) |
| 12/02/2004 | WO2004078909A8 Identification of antigen epitopes |
| 12/02/2004 | WO2004078215A3 Use of antibody conjugated deoxycytidine kinase for adept |
| 12/02/2004 | WO2004073653A8 Methods for treating pain by administering a nerve growth factor antagonist and an nsaid and compositions containing the same |
| 12/02/2004 | WO2004037198A3 Antibody-mediated induction of tumor cell death |
| 12/02/2004 | WO2004035084A3 Formulation of glutarmic acid decarboxylase (gad65) and serum albumin |
| 12/02/2004 | WO2004013308A3 Maxs as modifiers of the axin pathway and methods of use |
| 12/02/2004 | WO2003078465A8 The use of an epitope of vascular endothelial growth factor receptor kdr/flk-1 |
| 12/02/2004 | WO2003063767A3 Rsv proteins, antibodies, compositions, methods and uses |
| 12/02/2004 | WO2003028632A3 Development of a preventive vaccine for filovirus infection in primates |
| 12/02/2004 | WO2003025119A3 Compositions comprising immunostimulatory oligonucleotides and uses thereof to enhance fc receptor-mediated immunotherapies |
| 12/02/2004 | WO2003011106A3 Internal image antibodies for optical imaging and therapy |
| 12/02/2004 | US20040242860 Compositions and methods for the diagnosis and treatment of tumor |
| 12/02/2004 | US20040242859 Moraxella (branhamella) catarrhalis polypeptides and corresponding dna fragments |
| 12/02/2004 | US20040242852 Bifunctional chelating agent for actinium |
| 12/02/2004 | US20040242851 Immunoglobulin specifiic for vascular endothelial growth factor receptor for use in treatment and prevention of tumor; angiogenesis inhibitors; antitumor agents; antimetastasis agents; immunotherapy |
| 12/02/2004 | US20040242844 Nucleotide sequences coding streptococcus capsular polysaccharide antigens for use in diagnosis and prevention of infections in mammals; veterinary medicine |
| 12/02/2004 | US20040242529 Vector encoding inactivated telomerase for treating cancer |
| 12/02/2004 | US20040242522 Polynucleotide vaccine formulations |
| 12/02/2004 | US20040242514 Xenogenic oligo or/and polyribonucleotides as agents for the treatment of malignant tumours |
| 12/02/2004 | US20040242483 Molecules, compositions, methods and kits for applications associated with flaviviruses |
| 12/02/2004 | US20040242481 Use of hmgb1 for the activation of dendritic cells |
| 12/02/2004 | US20040242471 Dormancy induced mycobacterium proteins |
| 12/02/2004 | US20040242458 VP1 of foot-and-mouth disease virus |
| 12/02/2004 | US20040241853 Introducing one or more mutations into a template double-stranded polynucleotide via hybridization, replication and amplification of random genomic double stranded and heterozygous oligonucleotides sequences; genomics and directed evolution |
| 12/02/2004 | US20040241842 Stimulation of thymus for vaccination development |
| 12/02/2004 | US20040241841 Incubating dendritic precursor cells such as monocytes and plasmacytoid dendritic cells with immunostimulatory oligonucleotide to generate antigen presenting cells for use in treatment of cell proliferative disorders; immunotherapy |
| 12/02/2004 | US20040241830 Screening drugs targeting the D-alanine branch of mycobacterial peptidoglycan biosynthesis; bioassay; microbiocides; genetic vaccines |
| 12/02/2004 | US20040241826 Mycobacterial antigens expressed during latency |
| 12/02/2004 | US20040241821 Replication competent yellow fever virus for propagation of immunoglobulin conjugate for use in detection tumor associated antigen expression and treatment of cell proliferative disorders in mammals; cancer diagnosis; immunotherapy |
| 12/02/2004 | US20040241805 Cell surface binding protein for use in treatment, diagnosis and prevention of cancer, inflammation, autoimmunity, allergy, asthma and nervous system disorders |
| 12/02/2004 | US20040241803 25 human secreted proteins |
| 12/02/2004 | US20040241702 Expression vector comprising nucleotide sequences coding novel gene which is expressed in prostate tissues for use in diagnosis, prognosis, treatment and prevention of cell proliferative disorders; immunotherapy |
| 12/02/2004 | US20040241689 Using immunoglobulins to bind cell surface receptor and prevent microbial infection; bactericides; immunotherapy; transport protein inhibition |
| 12/02/2004 | US20040241687 Bacterial polypeptide for use in developing genetic vaccine for prevention and treatment of respiratory system disorders |
| 12/02/2004 | US20040241686 Vector comprising nucleotide sequences coding oncogenic protein for use in identication of modulators for treatment and prevention of cell proliferative and metabolic disorders |
| 12/02/2004 | US20040241671 Sequences involved in phenomena of tumour suppression, tumour reversion, apoptosis and/or virus resistance and their us as medicines |
| 12/02/2004 | US20040241652 Vector comprising nucleotide sequences coding fusion protein for use in identifying modulators to treat and prevent infection and cell proliferative disorders |
| 12/02/2004 | US20040241642 Polynucleotide fragments of an infections human endogenous retrovirus |
| 12/02/2004 | US20040241641 Monoclonal antibody for prevention and treatment of human immunodeficiency viral infection; immunotherapy |
| 12/02/2004 | US20040241638 Bacterial polypeptide for use in developing genetic vaccine for prevention and treatment of respiratory system disorders |
| 12/02/2004 | US20040241310 Method of producing antibodies ex-vivo |
| 12/02/2004 | US20040241193 Novel composition |
| 12/02/2004 | US20040241192 Administering a tryptanthrin compound, e.g., 8-nitroindolo[2,1-b]quinazoline-6,12-dione, to potentiate the immune response to an antigen; immunostimulants; small molecule immune potentiators; immunotherapy for infectious diseases; anticarcinogenic agents; vaccine adjuvant compositions and kits |
| 12/02/2004 | US20040241191 Recombinant vaccine against West Nile virus |
| 12/02/2004 | US20040241190 Safety features and immunogenicity resulting for live or killed attenuated mutant Neisseria, e.g., N. meningitidis, having auxotrophic mutation, e.g., AroA or AroB, capsule mutation, e.g., synX or galE, and also mutation reducing bacterial recombination or exogenous DNA uptake |
| 12/02/2004 | US20040241187 An inactivated, disrupted influenza virus preparation of a hemagglutinin antigen stabilised by alpha-tocopherol succinate in the absence of thiomersal or at low levels of thiomersal; hemagglutinin detectable by a single radial immunoassay (SRID); mercury-free preservative; administering by any route |
| 12/02/2004 | US20040241183 Human lymphocyte vaccine adjuvant |
| 12/02/2004 | US20040241182 lymphocytes; immunogens; fusion proteins; for treatment/prevention of infection |
| 12/02/2004 | US20040241181 Preferentially inducing a more potent CD8+ T cell response to an immunogen by delivering a recombinant simian adenovirus comprising a nucleic acid molecule encoding an immunogen under the control of gene expression regulatory sequences directing expression of the immunogen; HIV; rabies; papilloma virus |
| 12/02/2004 | US20040241178 Allergen peptide fragments and use thereof |
| 12/02/2004 | US20040241177 Novel compositions and uses therefor |
| 12/02/2004 | US20040241176 Method of producing membrane vesicles |
| 12/02/2004 | US20040241175 Antigen targeting |
| 12/02/2004 | US20040241171 Leukocyte inactivation module |
| 12/02/2004 | US20040241168 Compositions and methods for the treatment and clinical remission of psoriasis |
| 12/02/2004 | US20040241167 CD4/CD25 antigen containing cell, interleukin, CD8/CD28 antigen containing cell, and vitamin D3; for generating tolerogenic antigen-presenting cell; kits; for treatment of autoimmune diseases such as AIDS, cancer, and Hepatitis C-related disorders |
| 12/02/2004 | US20040241166 Use of inhibitors of ikk-beta and method for discovery of said inhibitors |
| 12/02/2004 | US20040241164 Use of antibodies having high affinity for soluble ab to treat conditions and diseases related to ass |
| 12/02/2004 | US20040241163 Secreted human cytomegalovirus protein or fragment thereof binds rantes chemokine; for treating chemokine-associated inflammatory or immune pathological conditions such as transplant rejection, arteriosclerosis, rheumatoid arthritis, asthma, endometriosis, and cancer |
| 12/02/2004 | US20040241160 Vegfr-1 antibodies to treat breast cancer |
| 12/02/2004 | US20040241158 Targetting antibodies containing haptens, cleaning agent, and drug delivery agent; tissue-directed therapy; solid phase synthesis |
| 12/02/2004 | US20040241152 Methods for inducing an immune response with an elevated th1/th2 ratio, by intracellular induction of nfkappab |
| 12/02/2004 | US20040241147 antigen presenting cells which express major histocomatibility complexes, used as vaccines |
| 12/02/2004 | US20040241143 Peptides for inducing cytotoxic T lymphocyte responses to hepatitis B virus |
| 12/02/2004 | US20040241140 Expression vectors able to elicit improved immune response and methods of using same |
| 12/02/2004 | US20040241137 vaccines comprising antigen bearing targets and fusion polypeptide having amino acid sequences which can bind to a carbohydrate and serve as and ligands for cell surface polypeptide of leukocytes |
| 12/02/2004 | US20040241088 Method for evaluating the efficacy of certain cancer treatments |
| 12/02/2004 | DE10321029A1 Arzneimittel mit Selenit Drugs with selenite |
| 12/02/2004 | CA2528521A1 Disease prevention and vaccination prior to thymic reactivations |
| 12/02/2004 | CA2526403A1 New enterovirus, vaccines, medicaments and diagnostic kits |
| 12/02/2004 | CA2526275A1 Hypoallergenic variants of the parietaria judaica major allergens, uses thereof and compostitions comprising them |
| 12/02/2004 | CA2526069A1 Modified antiviral peptides with increased activity and cell membrane affinity |
| 12/02/2004 | CA2525840A1 Ovr115 antibody composition and methods of use |
| 12/02/2004 | CA2524860A1 Multivalent meningococcal derivatized polysaccharide-protein conjugates and vaccine |
| 12/02/2004 | CA2431080A1 Enhancement of anticancer immunity through inhibition of arginase |
| 12/01/2004 | EP1482041A1 Nnl6 tie receptor tyrosine kinase ligand homologues |
| 12/01/2004 | EP1482040A2 NL3 TIE receptor tyrosine kinase ligand homologues |
| 12/01/2004 | EP1481992A2 Humanized antibodies that sequester amyloid beta peptide |
| 12/01/2004 | EP1481991A1 Allergenic protein of natural rubber |
| 12/01/2004 | EP1481989A1 A-33 related antigens and their pharmacological uses |
| 12/01/2004 | EP1481985A1 Modified hepatitis C virus (HCV) NS3 for medical treatment |
| 12/01/2004 | EP1481688A1 Solidified tissue immunological adjuvant |
| 12/01/2004 | EP1481057A1 System and method for the production of recombinant glycosylated proteins in a prokaryotic host |
| 12/01/2004 | EP1481053A2 Method of making cs6 antigen vaccine for treating, preventing, or inhibiting enterotoxigenic escherichia coli infections |